These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16544042)

  • 1. [Congenital adrenal hyperplasia newborn screening: Rio de Janeiro experience].
    Cardoso CB; Fonseca AA; Oliveira Mde F; Pereira BB; Guimarães MM
    Arq Bras Endocrinol Metabol; 2005 Feb; 49(1):112-9. PubMed ID: 16544042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital Adrenal Hyperplasia: Time to Replace 17OHP with 21-Deoxycortisol.
    Miller WL
    Horm Res Paediatr; 2019; 91(6):416-420. PubMed ID: 31450227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of CYP21A2 can optimize the follow-up of positive results in newborn screening for congenital adrenal hyperplasia.
    Silveira EL; Elnecave RH; dos Santos EP; Moura V; Pinto EM; van der Linden Nader I; Mendonca BB; Bachega TA
    Clin Genet; 2009 Dec; 76(6):503-10. PubMed ID: 19930153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn screening for congenital adrenal hyperplasia in Cuba: six years of experience.
    González EC; Carvajal F; Frómeta A; Arteaga AL; Castells EM; Espinosa T; Coto R; Pérez PL; Tejeda Y; Del Río L; Segura MT; Almenares P; Robaina R; Fernández JL
    Clin Chim Acta; 2013 Jun; 421():73-8. PubMed ID: 23481450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weight-adjusted neonatal 17OH-progesterone cutoff levels improve the efficiency of newborn screening for congenital adrenal hyperplasia.
    Hayashi G; Faure C; Brondi MF; Vallejos C; Soares D; Oliveira E; Brito VN; Mendonca BB; Bachega TA
    Arq Bras Endocrinol Metabol; 2011 Nov; 55(8):632-7. PubMed ID: 22218447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal screening for congenital adrenal hyperplasia: experience and results in Argentina.
    Gruñieiro-Papendieck L; Chiesa A; Mendez V; Prieto L
    J Pediatr Endocrinol Metab; 2008 Jan; 21(1):73-8. PubMed ID: 18404975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum 21-Deoxycortisol, 17-Hydroxyprogesterone, and 11-deoxycortisol in classic congenital adrenal hyperplasia: clinical and hormonal correlations and identification of patients with 11beta-hydroxylase deficiency among a large group with alleged 21-hydroxylase deficiency.
    Tonetto-Fernandes V; Lemos-Marini SH; Kuperman H; Ribeiro-Neto LM; Verreschi IT; Kater CE
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2179-84. PubMed ID: 16551734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal screening for congenital adrenal hyperplasia.
    Barra CB; Silva IN; Pezzuti IL; Januário JN
    Rev Assoc Med Bras (1992); 2012; 58(4):459-64. PubMed ID: 22930025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ten-year evaluation of a Neonatal Screening Program for congenital adrenal hyperplasia.
    Nascimento ML; Cristiano AN; Campos Td; Ohira M; Cechinel E; Simoni G; Lee Jv; Linhares RM; Silva PC
    Arq Bras Endocrinol Metabol; 2014 Oct; 58(7):765-71. PubMed ID: 25372587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Measurement of 17 OH progesterone in blood in Chilean newborns: antecedents for implementing a grogram for the neonatal detection of congenital adrenal hyperplasia].
    Cattani A; Reyes ML; Azócar M; Soto J; Romeo E; Valdivia L; Poggi H; Foradori A
    Rev Med Chil; 2000 Oct; 128(10):1113-8. PubMed ID: 11349510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
    Kopacek C; de Castro SM; Prado MJ; da Silva CM; Beltrão LA; Spritzer PM
    BMC Pediatr; 2017 Jan; 17(1):22. PubMed ID: 28095810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal 17-hydroxyprogesterone levels adjusted according to age at sample collection and birthweight improve the efficacy of congenital adrenal hyperplasia newborn screening.
    Hayashi GY; Carvalho DF; de Miranda MC; Faure C; Vallejos C; Brito VN; Rodrigues AS; Madureira G; Mendonca BB; Bachega TA
    Clin Endocrinol (Oxf); 2017 Apr; 86(4):480-487. PubMed ID: 27978607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia.
    Therrell BL; Berenbaum SA; Manter-Kapanke V; Simmank J; Korman K; Prentice L; Gonzalez J; Gunn S
    Pediatrics; 1998 Apr; 101(4 Pt 1):583-90. PubMed ID: 9521938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons learned from 5 years of newborn screening for congenital adrenal hyperplasia in the Czech Republic: 17-hydroxyprogesterone, genotypes, and screening performance.
    Votava F; Novotna D; Kracmar P; Vinohradska H; Stahlova-Hrabincova E; Vrzalova Z; Neumann D; Malikova J; Lebl J; Matern D
    Eur J Pediatr; 2012 Jun; 171(6):935-40. PubMed ID: 22234478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of spironolactone on neonatal screening for congenital adrenal hyperplasia.
    Terai I; Yamano K; Ichihara N; Arai J; Kobayashi K
    Arch Dis Child Fetal Neonatal Ed; 1999 Nov; 81(3):F179-83. PubMed ID: 10525019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels.
    Allen DB; Hoffman GL; Fitzpatrick P; Laessig R; Maby S; Slyper A
    J Pediatr; 1997 Jan; 130(1):128-33. PubMed ID: 9003862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of Patients with Classic Congenital Adrenal Hyperplasia Missed on the Newborn Screen.
    Saroufim R; Nebesio TD; Eugster EA
    Horm Res Paediatr; 2024; 97(5):470-476. PubMed ID: 37992692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3β-hydroxysteroid dehydrogenase type II deficiency on newborn screening test.
    Araújo VG; Oliveira RS; Gameleira KP; Cruz CB; Lofrano-Porto A
    Arq Bras Endocrinol Metabol; 2014 Aug; 58(6):650-5. PubMed ID: 25211449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma 21-deoxycortisone: a sensitive additive tool in 21-hydroxylase deficiency in newborns.
    Fiet J; Bachelot G; Sow C; Farabos D; Helin N; Eguether T; Dufourg MN; Bellanne-Chantelot C; Ribaut B; Bachelot A; Young J; Houang M; Lamazière A
    Eur J Endocrinol; 2024 Aug; 191(2):204-210. PubMed ID: 39137138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency of non-classical congenital adrenal hyperplasia form among children with persistently elevated levels of 17-hydroxyprogesterone after newborn screening.
    Castro PS; Rassi TO; Araujo RF; Pezzuti IL; Rodrigues AS; Bachega TASS; Silva IN
    J Pediatr Endocrinol Metab; 2019 May; 32(5):499-504. PubMed ID: 31028712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.